PRL and COVID-19: Our publication trend analysis revealed that among the 128 research articles, 38 studies assessed male reproductive hormones (such as testosterone, luteinizing hormone, follicle-stimulating hormone, prolactin, estradiol, and inhibin) in COVID-19 patients with reproductive issues.